Official UK procurement notice
Generic Drugs - Tablets and Capsules
Authority: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) (NHS & healthcare)·Consortium: 2 public authorities
What is being bought
Published requirement descriptionGeneric Drugs - Tablets & Capsules
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1AwardedRenewal
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (5)
- Financial (overall cost of contract): 85
- Price: 65
- Price stability: 16
- Minimum Order Value: 4
- Social Value/Community Benefits: 15
Published award criteria (6)
- Product Quality/Acceptability: Pass/Fail
- Financial (overall cost of contract): 85
- Social Value/Community Benefits: 15
- Price: 65
- Price stability: 16
- Minimum Order Value: 4
- Suitability
Any supplier may be disqualified who does not respond to the following in the
requisite manner:
- ENTERING GENERAL Qualification SUPPLIER INFORMATION NHS Wales Shared Services Partnership Procurement Services utilizes Sell2Wales to manage and assess general prequalification information in the form of a profile.
Candidates are requested to Register company information on the Sell2Wales website at ww.sell2wales.co.uk.
- SUBMISSION OF TENDER AND PROCUREMENT SPECIFIC INFORMATION
(i)Candidates should register on the NHS Wales Shared Services Partnership Procurement Services eTendering portal etenderwales.bravosolution.co.uk/nhs ↗
(ii) Once registered, candidates must submit their tender as follows a) login to NHS Wales Shared Services Partnership Procurement Services eTendering portal b) select 'Respond to OJEU advert and ITT c) select 'ITTs Open To All Suppliers' d) access listing relating to the contract (title Lenalidomide) and view details e) click on 'Express Interest' button in the 'Actions' box on the left hand side of the page
(iii) Once you have expressed interest, the ITT will move to 'My ITTs', where you can download additional documentation and where you can construct your reply as instructed. You must then publish your reply using the publish button
(iv) For any support in submitting your tender, please contact the eTendering helpdesk on 08000112470 or at [email protected]
- Price carries 170 of 185 points: a 10% discount moves about 17 points. This one is won on the number: sharpen the price before polishing the prose.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Yes
- First published
- 14 Jun 2023, 14:28 BST
- Last source update
- 7 Mar 2024, 13:46 GMT
- Award evaluation window
- 14 Jul 2023 – …
- Authority reference
PAD-OJEU-52442- FTS notice number
2024/S 000-007348- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03d62bFind a Tender
Publisher note: 1. The contracting authority reserves the right to use an electronic reverse auction. 2. If and when this requirement is offered for tender, this may be done in whole or in part via electronic means using the internet. 3. The contracting authority is not bound to award a contract in whole or part. 4. The contracting authority will not bear the tender costs of any of the tenderers. 5. In reference to I.1.9 (Variants) to the extent permitted, if at all, in the tender documents. 6. This notice is being placed by NHS Wales Shared Services Partnership – Procurement Services. For the purpose of this procurement, the awarding authority will be Velindre NHS Trust. 7. This advertisement is placed by NHS Wales Shared Services Partnership - Procurement Services on behalf of participating LHB's/Trusts in Wales for the totality of those LHB/Trust specific contractual arrangements. 8. The Framework to be let for 24 months with an option to extend for up to 24 months.
How it was run
Official noticeTender documents are also served through a separate tool: http://www.etenderwales.bravosolution.co.uk/nhs/ ↗
- Submission deadline
- 14 Jul 2023, 12:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Participation fee
- document
- Bids opened
- 14 Jul 2023, 12:01 BST
Timeline
14 Jul 2023 → 7 Mar 2024 · 4 dates- Submission deadline14 Jul 2023, 12:00 BST
- Bids opened14 Jul 2023, 12:01 BST
- Contract starts1 Feb 2024
- Notice published7 Mar 2024, 13:46 GMT
Notice history
2 events · 2 releases on Find a Tender · since 7 Mar 2024- Status changed to complete7 Mar 2024, 13:46 GMT
- Buyer details updated7 Mar 2024, 13:46 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd | £4,254 † | — | Awarded |
| Chiesi Limited | £33,344 † | — | Awarded |
| Clydesdale Pharma ltd | £12,190 † | — | Awarded |
| Colonis Pharma Ltd | £193,672 † | — | Awarded |
| Crescent Pharma Limited | £506,728 † | — | Awarded |
| CST Pharma Ltd | £43,648 † | — | Awarded |
| Day Lewis Medical Ltd | £187,660 † | — | Awarded |
| Dr Falk Pharma UK Ltd | £47,800 † | — | Awarded |
| Dr Reddy's Laboratories (UK) Ltd | £170,199 † | — | Awarded |
| DRUGSRUS LTD | £707,827 † | — | Awarded |
41 further award records carry no date or value.
Contracts
Generic Drugs - Tablets & Capsules · Abbvie Ltd
- Signed
- 1 Feb 2024
- Value
- £4,254
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules · Chiesi Limited
- Signed
- 1 Feb 2024
- Value
- £33,344
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules · Clydesdale Pharma ltd
- Signed
- 1 Feb 2024
- Value
- £12,190
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules · Colonis Pharma Ltd
- Signed
- 1 Feb 2024
- Value
- £193,672
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules · Crescent Pharma Limited
- Signed
- 1 Feb 2024
- Value
- £506,728
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules · CST Pharma Ltd
- Signed
- 1 Feb 2024
- Value
- £43,648
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules · Day Lewis Medical Ltd
- Signed
- 1 Feb 2024
- Value
- £187,660
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules · Dr Falk Pharma UK Ltd
- Signed
- 1 Feb 2024
- Value
- £47,800
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules · Dr Reddy's Laboratories (UK) Ltd
- Signed
- 1 Feb 2024
- Value
- £170,199
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules · DRUGSRUS LTD
- Signed
- 1 Feb 2024
- Value
- £707,827
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £464,695
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £1,086,929
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £13,980
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £14,574
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £225,778
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £1,876
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £146,259
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £384,383
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £586,036
- Period
- … – 31 Jan 2027
- Status
- active
Generic Drugs - Tablets & Capsules
- Signed
- 1 Feb 2024
- Value
- £92,265
- Period
- … – 31 Jan 2027
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 58bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- eTenderwalesContracting authorityCentral purchasing bodyBody governed by public lawHealth
Bidders & participating suppliers
51 commercial parties on the notice · 50 awardedThe first 50 of 51 commercial parties (by name); the JSON mirror lists them all.
- AbbVie LimitedAwarded supplier
- Accord UK LtdAwarded supplier
- Alliance PharmaceuticalsAwarded supplier
- Aristo PharmaAwarded supplier
- Aspire Pharma LtdAwarded supplier
- Aurobindo ( Milpharm)Awarded supplier
- Baxter Health Care LimitedAwarded supplier
- Bristol Laboratories LtdAwarded supplier
- Brown & Burk UK LtdAwarded supplier
- CST PharmaAwarded supplier
Show 40 more suppliers
- Chiesi LimitedAwarded supplier
- Clydesdale Pharma LtdAwarded supplier
- Colonis Pharma LimitedAwarded supplier
- Crescent Pharma LtdAwarded supplier
- Day Lewis MedicalAwarded supplier
- Dr Falk Pharma UK LtdAwarded supplier
- Dr Reddy's Laboratories UK LtdAwarded supplier
- Drugsrus LimitedAwarded supplier
- Ennogen HealthCare International LimitedAwarded supplier
- Esteve Pharmaceuticals LtdAwarded supplier
- Ferring PharmaceuticalsAwarded supplier
- Flynn Pharma LtdAwarded supplier
- Gerot Lannach UK LtdAwarded supplier
- Glaxo SmithklineAwarded supplier
- Glenmark PharmaceuticalsAwarded supplier
- Kent PharmaceuticalsAwarded supplier
- MartindaleAwarded supplier
- Medac Pharma LLPAwarded supplier
- Medreich PLCAwarded supplier
- Mercury Pharmaceuticals LtdAwarded supplier
- Morningside Pharmaceuticals LimitedAwarded supplier
- Napp Pharmaceutical GroupAwarded supplier
- Neon Healthcare LtdAwarded supplier
- NeuraxpharmAwarded supplier
- Novartis Pharmaceuticals UK LimitedAwarded supplier
- Organon Pharma ( UK ) LimitedAwarded supplier
- Perennial Pharma LtdAwarded supplier
- Pfizer LimitedAwarded supplier
- Phoenix LabsAwarded supplier
- Resolution Chemicals LimitedAwarded supplier
- Roche Products LimitedAwarded supplier
- Sandoz LtdAwarded supplier
- SanofiAwarded supplier
- Selective SuppliesAwarded supplier
- Sun Pharma UKAwarded supplier
- Teva UK LimitedAwarded supplier
- Thornton & RossAwarded supplier
- Tillomed Laboratories LtdAwarded supplier
- Viatris UK Healthcare LimitedAwarded supplier
- Wockhardt UK LimitedAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria